Inflammatory bowel disease

Editorial
Year 2024 / Volume 116 / Number 12
657-660
DOI: 10.17235/reed.2024.10764/2024
Fernando Gomollón,
Except for some surgical techniques, up to 1940 the clinical course of inflammatory bowel disease was determined by its own natural history: most medical interventions even worsened prognosis. The empyrical...
Reader rating:
Share Button
Letter
Year 2024 / Volume 116 / Number 12
732-733
DOI: 10.17235/reed.2024.10140/2023
João Correia, Maria Manuela Estevinho, Pedro Mesquita, Catarina Costa, Teresa Freitas,
A 66-year-old man was admitted to the emergency department due to malaise, fatigue and anorexia for the last 2 weeks. He presented no fever, no respiratory or gastrointestinal symptoms. The patient had...
Reader rating:
Share Button
Letter
Year 2024 / Volume 116 / Number 12
724-725
DOI: 10.17235/reed.2024.10865/2024
Carolina Broco Fernández, Mónica Sierra Ausín, Irene Latras Cortés, Verónica Patiño Delgadillo, Patricia Suárez Álvarez, Francisco Jorquera Plaza,
We present the case of a 64-year-old male diagnosed with corticosteroid-dependent ulcerative colitis in 1999, who underwent total proctocolectomy with a J-pouch in 2005. Three years later, he developed...
Reader rating:
Share Button
Original
Year 2024 / Volume 116 / Number 11
606-612
DOI: 10.17235/reed.2024.10489/2024
José Ramón Lorente, José María Paredes, Pilar Llopis, Tomás Ripollés, Alba Voces, Ángela Algarra, Carmina Asencio, Patricia Latorre, Nadia Moreno, Antonio López-Serrano, Eduardo Moreno-Osset,
Background: anti-TNF drugs have revolutionized the treatment of Crohn’s disease (CD) and have set new therapeutic targets. A direct correlation between anti-TNF trough levels and endoscopic healing in...
Reader rating:
Share Button
Letter
Year 2024 / Volume 116 / Number 11
645-646
DOI: 10.17235/reed.2024.10168/2023
Álvaro Yagüe Parada, Orencio Bosch Esteva, Daniel Calero Barón, Andrea Blanco Fernández, Víctor Manuel Castellano Megías, Sara Aurora Rodríguez Vargas,
Epstein-Barr virus-positive mucocutaneous ulcer (EBVMCU) is a new entity recently included in the classification of B-cell lymphoproliferative disorders associated with Epstein-Barr virus (EBV). It is...
Reader rating:
Share Button
Letter
Year 2024 / Volume 116 / Number 11
644-645
DOI: 10.17235/reed.2024.10212/2023
Sucong Lyu, Guoqiang Zhong, Yangda Song, Yan Sun, Jin Li, Xiujing Fan, Qing Qing, Mingsong Li,
Ustekinumab (UST) is a human IgG1 monoclonal antibody that targets to the share p40 subunit of interleukin-12(IL-12) and IL-23. Evidence has shown that UST therapy is well tolerated and effective in inducing...
Reader rating:
Share Button
Letter
Year 2024 / Volume 116 / Number 11
640-641
DOI: 10.17235/reed.2024.10166/2023
Paula Calderón, Rodrigo Quera, Paulina Núñez, Lilian Flores,
Despite advances in the treatment of inflammatory bowel disease, particularly with biological therapies and new small molecules, a significant gap still exists in achieving persistent remission from a...
Reader rating:
Share Button
Letter
Year 2024 / Volume 116 / Number 11
638-640
DOI: 10.17235/reed.2024.10144/2023
Xiaofang Xu, Xiaodan Lv, Zhixi Huang, Bing Han, Ziqian Huang, Shiquan Li, Junhua Fan, Xiaoping Lv,
Background Pyoderma gangrenosum (PG) is a rare extraintestinal manifestation of inflammatory bowel disease. In recent years, the use of biologics in PG has been on the rise and has shown promising results....
Reader rating:
Share Button
Letter
Year 2024 / Volume 116 / Number 10
580-581
DOI: 10.17235/reed.2024.10677/2024
Óscar Moralejo Lozano, Lucía Ruano Díaz, María Abanades Tercero, Concepción Muñoz Rosas, Rosario Salmoral Luque, Concepción González de Frutos, Rafael Ángel Gómez Rodríguez,
A 39-year-old woman with a history of Crohn’s disease presents at the Emergency Room for a 2-hour long colicky abdominal pain with bloating, vomiting and no gas passing. She refers an accidental ingestion...
Reader rating:
Share Button
Original
Year 2024 / Volume 116 / Number 9
478-483
DOI: 10.17235/reed.2024.10305/2024
Clara Ramos Belinchón, Helena Martínez-Lozano, Clara Serrano Moreno, Diego Hernández Castillo, Pablo Lois Chicharro, Pablo Ferreira Ocampo, Ignacio Marín-Jiménez, Irene Bretón Lesmes, Luis Menchén,
Background: obesity affects many patients with inflammatory bowel disease (IBD). Glucagon-like peptide (GLP)-1 agonists are a promising therapy for obese patients. However, there is a lack of evidence...
Reader rating:
Share Button

Page 1 of 17
1
2
3
4
5
6
7
>>
Submission and tracking of manuscripts
Instructions to authors

Submission and tracking

Asociación Española de Ecografía Digestiva Sociedad Española de Endoscopia Digestiva Sociedad Española de Patología Digestiva
The Spanish Journal of Gastroenterology is the official organ of the Sociedad Española de Patología Digestiva, the Sociedad Española de Endoscopia Digestiva and the Asociación Española de Ecografía Digestiva
Cookie policy Privacy Policy Legal Notice © Copyright 2024 y Creative Commons. The Spanish Journal of Gastroenterology